Recent investigations of modeling FAD with patient-specific iPSCs showed relatively late pathological manifestations of AD related to APP metabolism, Aβ accumulation or tau phosphorylation in neuronal or glia cells [15–19, 21, 22]. Here, MAPT is linked to Alzheimer disease.